LIVERAMP HOLDINGS, INC.

RAMP

CIK 0000733269 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$212M
↑+8.6% +$17Mvs FY2024 (Q4)
Operating Income
$40M
↑+169.4% +$25Mvs FY2024 (Q4)
Net Income
$36M
↑+225.6% +$25Mvs FY2024 (Q4)
Gross Profit
$153M
↑+8.6% +$12Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
60/100
  • Profitability
    0ROIC 0.3% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 2.65 (above 1.5 = solid)
  • Leverage
    82D/E 0.35 (under 0.5 = conservative)
  • Efficiency
    31Asset Turnover 0.60x (1.0+ = capital-efficient)
  • Growth
    45Revenue YoY +8.6% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 18.6% · trend +8.2pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project RAMP's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 27.6%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$77.14
Total enterprise IV
$5.10B
Diluted shares
0.07B
Terminal PV
$3.96B (78% of total)
Year-5 FCF
$467M
YearProjected FCFDiscounted PV
+1$191M$174M
+2$239M$197M
+3$299M$224M
+4$373M$255M
+5$467M$290M
Terminal$6.38B$3.96B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$1M
investment in PP&E
Stock buybacks (TTM)
$144M
share count reduction
Stock-based comp (TTM)
$88M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$1.27B
everything owned
Total liabilities
$142M
everything owed
Stockholders' equity
$962M
shareholder claim
Net debt
$-227M
Net cash position ($227M)

Recent performance · 67 quarters

Revenue↑+8.6% +$17M
$212M
Net Income↑+255.7% +$29M
$40M
Free Cash Flow↓-61.4% -$28M
$17M
Operating Margin↑+11.1pts
18.6%

Drill down